rs41456348
Positions:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The ENST00000387372.1(MT-TQ):n.65A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Mitomap GenBank:
𝑓 0.0088 ( AC: 535 )
Consequence
MT-TQ
ENST00000387372.1 non_coding_transcript_exon
ENST00000387372.1 non_coding_transcript_exon
Scores
Mitotip
Uncertain
Clinical Significance
ADPD-/-Hearing-Loss-&-Migraine-/-autism-spectrum-/-intellectual-disability
Conservation
PhyloP100: -1.81
Genes affected
MT-TQ (HGNC:7495): (mitochondrially encoded tRNA glutamine)
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant M-4336-T-C is Benign according to our data. Variant chrM-4336-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 9615.We mark this variant Likely_benign, oryginal submissions are: {Benign=2, Uncertain_significance=1}.
BS1
High frequency in mitomap database: 0.0088
BS2
High AC in GnomadMitoHomoplasmic at 737
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRNQ | TRNQ.1 use as main transcript | n.65A>G | non_coding_transcript_exon_variant | 1/1 | |||
TRNI | TRNI.1 use as main transcript | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MT-TQ | ENST00000387372.1 | n.65A>G | non_coding_transcript_exon_variant | 1/1 | |||||
MT-TI | ENST00000387365.1 | downstream_gene_variant |
Frequencies
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
We have no GnomAD4 genomes data on this position. Probably position not covered by the project.
Mitomap GenBank
AF:
AC:
535
Gnomad homoplasmic
AF:
AC:
737
AN:
56424
Gnomad heteroplasmic
AF:
AC:
1
AN:
56424
Alfa
AF:
Hom.:
Mitomap
ADPD-/-Hearing-Loss-&-Migraine-/-autism-spectrum-/-intellectual-disability
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Sensorineural deafness and migraine Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2001 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | May 26, 2015 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 17, 2020 | - - |
Juvenile myopathy, encephalopathy, lactic acidosis AND stroke Benign:1
Benign, criteria provided, single submitter | clinical testing | Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine | Jul 12, 2019 | The NC_012920.1:m.4336T>C variant in MT-TQ gene is interpreted to be a Benign variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes reported in the guidelines: BS1, BS4 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mitotip
Uncertain
Hmtvar
Pathogenic
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at